Perrigo | PRGO - Ebitda


Perrigo reported $258.8M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Abbott USD 3.09B 44M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Dr.Reddys Laboratories INR 20.89B 117M Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
J&J USD 9.52B 389M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Nestle CHF 9.09B 594M Jun/2025
Pacira USD 38.71M 10.65M Dec/2025
Perrigo USD 258.8M 37.3M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Reckitt Benckiser GBP 1.95B 708M Jun/2025
Sanofi EUR 4.84B 2.95B Sep/2025
Supernus Pharmaceuticals USD 48.5M 6.6M Dec/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025
Zoetis USD 1.04B 87M Sep/2025